Decision-making in HIV clinical trials: a study with patients enrolled in antiretroviral trials

dc.contributor.authorFeijoo-Cid, Maria
dc.contributor.authorRivero-Santana, Amado
dc.contributor.authorMoriña, David
dc.contributor.authorCesar, Carina
dc.contributor.authorFink, Valeria
dc.contributor.authorSued, Omar
dc.date.accessioned2024-04-10T17:45:21Z
dc.date.available2024-04-10T17:45:21Z
dc.date.issued2021
dc.descriptionFil: Feijoo-Cid M. Department of Nursing, Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; Grup de REcerca Multidisciplinar en SAlut i Societat (GREMSAS); Spaines_ES
dc.description.abstractAbstract Objective: To explore the decisional process of people living with human immunodeficiency virus (HIV) currently enrolled in antiretroviral clinical trials. Method: Cross-sectional retrospective study. Outcome variables were reasons to participate, perceived decisional role (Control Preference Scale), the Decisional Conflict Scale and the Decisional Regret Scale. Descriptive statistics were calculated, and associations among these variables and with sociodemographic and clinical characteristics were analyzed with non-parametric techniques. Results: Main reasons to participate were gratitude towards Fundación Huesped (47%), the doctor's recommendation (32%), and perceived difficulty to access treatment in a public hospital (28%). Most patients thought that they made their decision alone (54.8%) or collaboratively with the physician (43%). Decisional conflict was low, with only some conflict in the support subscale (median=16.67). Education was the only significant correlate of the total decisional conflict score (higher in less educated patients; p=0.018), whereas education, recent diagnosis, living alone, lower age, being man and doctor's recommendation to go to Fundación Huésped related to higher conflict in different subscales. Nobody regretted to participate. Conclusions: The decision making regarding participation in HIV trials, from the perspective of participants, was made respecting their autonomy and with very low decisional conflict. Currently, patients show no signs of regret. However, even in this favorable context, results highlight the necessity of enhancing the decision support in more vulnerable patients (e.g., less educated, recently diagnosed or with less social support), thus warranting equity in the quality of the decision making process. Keywords: Clinical trial; Conflicto decisional; Decisional conflict; Ensayo clínico; Human immunodeficiency virus; Participación del paciente; Patient participation; Virus de la inmunodeficiencia humana. ©2020 SESPAS. Published by Elsevier España, S.L.U. This is an open access article under the CCBY-NC-NDlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).es_ES
dc.formatapplication/pdfes_ES
dc.identifier.doihttps://doi.org/10.1016/j.gaceta.2019.11.008
dc.identifier.urihttps://repositorio.huesped.org.ar/handle/123456789/954
dc.languageENGes_ES
dc.provenancePublishedes_ES
dc.relation.ispartofseriesGaceta Sanitaria;2021 May-Jun;35(3):264-269.
dc.rightsopenAccesses_ES
dc.subjectEnsayo Clínicoes_ES
dc.subjectVIHes_ES
dc.subjectParticipación del Pacientees_ES
dc.titleDecision-making in HIV clinical trials: a study with patients enrolled in antiretroviral trialses_ES
dc.typeArticuloes_ES

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
10.1016j.gaceta.2019.11.008.pdf
Size:
384 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: